Autism Spectrum Disorder Treatment Market - Top Companies and Manufacturers

Companies Dominating the Autism Spectrum Disorder Treatment Landscape

Pfizer, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Curemark LLC
Yamo Pharmaceuticals, LLC
Merck & Co Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services, Inc.
Bristol-Myer Squibb
Janssen Pharmaceuticals, Inc.
Axial Therapeutics, Inc.

Browse Key Market Insights with Data Illustration:

Autism Spectrum Disorder Treatment Market Size & Share, Forecast Report 2037

In the News

Novartis AG announced collaboration with Sangamo to research gene therapies for the treatment of autism spectrum disease. The top two brands will partner to develop gene therapies and other brain problems for ASD treatments. The agreement between Novartis and Sangamo provided the Brisbane-based firm with a net worth of approximately USD 75 million to accomplish the milestones in its commercial development.
Axial Therapeutics announced that the company received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for their lead candidate named AB-2004, which is a gut targeted, molecular therapeutic being studied for the treatment of irritability associated with ASD.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gaming PC is estimated at USD 2.44 billion.

The autism spectrum disorder treatment market size was valued at USD 2.32 billion in 2024 and is likely to cross USD 5.13 billion by 2037, expanding at more than 6.3% CAGR during the forecast period i.e., between 2025-2037. Growing government efforts on raising funds and awareness for autism as well as increasing research and development will boost the market growth.

North America industry is estimated to account for largest revenue share of 30% by 2037, impelled by research & development in the region.

The major players in the market are Pfizer, Inc., Novartis AG, Curemark LLC, Yamo Pharmaceuticals, LLC, Merck & Co Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Bristol-Myer Squibb, Janssen Pharmaceuticals, Inc., Axial Therapeutics, Inc.

Autism Spectrum Disorder Treatment Market - Top Companies and Manufacturers

Companies Dominating the Autism Spectrum Disorder Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the autism spectrum disorder treatment market?

Why is the autism spectrum disorder treatment sector gaining traction in near future?

Which region accounted for the largest autism spectrum disorder treatment industry share?

Who are the major autism spectrum disorder treatment players?